{"pagecount":5,"title":"The safety of testosterone supplementation therapy in prostate cancer","author":"James M. Dupree","bounds":[[909,1195],[909,1195],[909,1195],[909,1195],[909,1195]],"bookmarks":[{"title":"The safety of testosterone supplementation therapy in prostate cancer","page":1},{"title":"James M. Dupree, Gavin M. Langille, Mohit Khera and Larry I. Lipshultz","page":1},{"title":"Introduction","page":1},{"title":"TST\u2014effects on the prostate","page":1},{"title":"Hypogonadism and cancer risk","page":2},{"title":"TST and prostate cancer risk","page":3},{"title":"Conclusions","page":4},{"title":"Author contributions","page":5}]}